A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol

A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol

Bibliographic Details
Main Authors: Ma, Xiao-Wei, Guo, Xiao-Hui, Xiao, Xin-Hua, Guo, Li-Xin, Lv, Xiao-Feng, Li, Quan-Min, Gao, Yan
Format: Online
Language:English
Published: Science Press 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470020/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470020/

Similar Items